Immunotherapies
204 views | +0 today
Your new post is loading...
Your new post is loading...
Scooped by THERAVECTYS
Scoop.it!

Super Antibody Offers Potential HIV Treatment, Cure, Scientists Say

Super Antibody Offers Potential HIV Treatment, Cure, Scientists Say | Immunotherapies | Scoop.it
Powerful, broadly neutralizing antibodies produced by small group of HIV-positive individuals have ability to ward off virus replication in others
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

Local Radiation and Anti-Cancer Vaccines Can Magnify Effects of Immunotherapy

Local Radiation and Anti-Cancer Vaccines Can Magnify Effects of Immunotherapy | Immunotherapies | Scoop.it
By combining local radiation therapy and anti-cancer vaccines with checkpoint inhibitors it is possible to increase the response rate for immunotherapy agents.
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

A single injection of antibodies protected monkeys from HIV for nearly six months

A single injection of antibodies protected monkeys from HIV for nearly six months | Immunotherapies | Scoop.it
A new study has shown that a single injection of antibodies that target HIV can protect monkeys from contracting the virus for nearly six months. The study, published today in Nature, i
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

Will we see the end of HIV soon? Though ambitious, several strategies have scientists hopeful. “Shock and kill,” gene editing, and even a vaccine may even be available by the end of the decade.

Will we see the end of HIV soon? Though ambitious, several strategies have scientists hopeful.  “Shock and kill,” gene editing, and even a vaccine may even be available by the end of the decade. | Immunotherapies | Scoop.it
Closing in on 35 years since HIV was first discovered, medical science is now starting to see the possibility of a day when HIV will be curable.
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

Study discovers new HIV vaccine target

Study discovers new HIV vaccine target | Immunotherapies | Scoop.it
A team led by scientists at the National Institutes of Health (NIH) has reported a research trifecta.
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

93% of advanced leukaemia patients go into remission following immunotherapy treatment

93% of advanced leukaemia patients go into remission following immunotherapy treatment | Immunotherapies | Scoop.it
New therapy against leukaemia shows promising results in early-phase clinical trial.
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

A Brief History Of Vaccines

A Brief History Of Vaccines | Immunotherapies | Scoop.it
Vaccination was a major turning point in modern medicine, but it existed in primitive forms hundreds of years earlier.
more...
No comment yet.
Rescooped by THERAVECTYS from Biotech, Pharmas and ideas
Scoop.it!

Une prise de sang pour détecter tous types de cancer, la promesse d'Illumina

Une prise de sang pour détecter tous types de cancer, la promesse d'Illumina | Immunotherapies | Scoop.it

Détecter n'importe quel cancer avec un seul prélèvement sanguin, avant même l'apparition des premiers symptômes. C'est ce que promet Grail, le spin-off de l'entreprise de biotechnologie américaine Illumina. Qui est cette start-up qui a séduit Bill Gates et Jeff Bezos ?

 


Via Herve Ansanay
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

Using Biomarkers for Immunotherapy in Melanoma with Dr. Hamid

Using Biomarkers for Immunotherapy in Melanoma with Dr. Hamid | Immunotherapies | Scoop.it

The possibility of using biomarkers to select immunotherapy as a treatment option for patients with melanoma.
Omid Hamid, MD, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, The Angeles Clinic and Research Institute...

more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

SillaJen Shows Multiple Intravenous Doses of Oncolytic Immunotherapy Safe in ... - Immuno-Oncology News

SillaJen Shows Multiple Intravenous Doses of Oncolytic Immunotherapy Safe in ... - Immuno-Oncology News | Immunotherapies | Scoop.it
Read how SillaJen Shows Multiple Intravenous Doses of Oncolytic Immunotherapy Safe in Cancer Patients
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

What Is Cancer Immunotherapy?

What Is Cancer Immunotherapy? | Immunotherapies | Scoop.it
Cancer immunotherapy is rapidly becoming a major new weapon in the fight against this deadly disease. Here is a brief primer on this powerful new technology, as well as a look at where it's likely headed moving forward.
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

Adoptive Cell ImmunoTherapy (ACT) – Advancing Personalised Cancer Treatment - Immuno-Oncology News

Adoptive Cell ImmunoTherapy (ACT) – Advancing Personalised Cancer Treatment - Immuno-Oncology News | Immunotherapies | Scoop.it
In a special issue of the journal Immunotherapy a group of lead experts discuss the latest developments in adoptive cell immunotherapy and discuss new strategies to further enhance its use as a cancer treatment.
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

First-in-Human CRISPR Immunotherapy Would Target PD-1 | Onclive

First-in-Human CRISPR Immunotherapy Would Target PD-1 | Onclive | Immunotherapies | Scoop.it
At a time when PD-1 inhibitors are dominating the immunotherapy field, a team of researchers is seeking to use groundbreaking CRISPR gene editing technology for the first time in human beings to create an engineered T-cell agent that would knock out...
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

Genetically engineered HIV Vaccine moves to phase I human trial in summer of 2017 and other vaccine candidates in various trial stages

Genetically engineered HIV Vaccine moves to phase I human trial in summer of 2017 and other vaccine candidates in various trial stages | Immunotherapies | Scoop.it
A vaccine for HIV developed by Oregon Health Sciences University in collaboration with the California National Primate Research Center at the University of California, Davis, is moving toward clinical trials.
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

Cure for HIV Gets Closer as Researchers Snip Virus Out of Cells

Cure for HIV Gets Closer as Researchers Snip Virus Out of Cells | Immunotherapies | Scoop.it
Using a powerful new gene editing technique, scientists have now excised HIV genes from the genomes of animals using CRISPR, making it more possible to one day do the same in human patients
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

Researchers successfully excise HIV DNA from animals

Researchers successfully excise HIV DNA from animals | Immunotherapies | Scoop.it
Using gene editing technology, researchers at the Lewis Katz School of Medicine at Temple University have, for the first time, successfully excised a segment of HIV-1 DNA - the virus responsible for AIDS - from the genome...
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

Tumour immunology and immunotherapy

This animation created by Nature Reviews Cancer and Nature Reviews Immunology illustrates how tumour cells are sensed and destroyed by cells of the immun
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

The list of cancers that can be treated by immunotherapy keeps growing

The list of cancers that can be treated by immunotherapy keeps growing | Immunotherapies | Scoop.it
Two new studies reveal inroads against rare and intractable tumors.
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

Driving Cancer Immunotherapy | GEN Magazine Articles | GEN

Driving Cancer Immunotherapy | GEN Magazine Articles | GEN | Immunotherapies | Scoop.it
The stakes in immuno-oncology are too high for researchers to pull at cancer’s levers blindly. Whether they’re tracking T-cell clonal diversity, monitoring circulating tumor cells, or designing cancer-killing assays, researchers need a system.
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

Virus Shell Nanoparticles Vaccinate Cancers in Mice |

Virus Shell Nanoparticles Vaccinate Cancers in Mice | | Immunotherapies | Scoop.it

The magazine Science hailed cancer immunotherapy as the breakthrough of the year two years ago, and the field has been gaining traction since. The idea is

more...
No comment yet.
Rescooped by THERAVECTYS from Immunology, vaccine & infectious diseases
Scoop.it!

IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction : Nature Reviews Immunology : Nature Publishing Group

IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction : Nature Reviews Immunology : Nature Publishing Group | Immunotherapies | Scoop.it

In this Opinion article, we discuss the function of tissues as a crucial checkpoint for the regulation of effector T cell responses, and the notion that interleukin-15 (IL-15) functions as a danger molecule that communicates to the immune system...


Via Denis Hudrisier
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

Responses With Immunotherapy Versus Chemotherapy - OncLive

Responses With Immunotherapy Versus Chemotherapy
OncLive
In individuals with large tumor burden, clinicians may see a rapid reduction in disease that can occur with either chemotherapy or immunotherapy.
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

Immunotherapy: 5 Ways to Stop Cancer

This video is part of the Cancer Research Institute's series “Immunotherapy: 5 Ways to Stop Cancer.” For more information on treating cancer with ...
more...
No comment yet.
Scooped by THERAVECTYS
Scoop.it!

June Is Cancer Immunotherapy Month - CANCER RESEARCH Catalyst

June Is Cancer Immunotherapy Month - CANCER RESEARCH Catalyst | Immunotherapies | Scoop.it
In recognition of June as Cancer Immunotherapy Month, the American Association for Cancer Research (AACR) has compiled a number of resources.
more...
No comment yet.